{
  "document_metadata": {
    "page_number": "5",
    "document_number": "734",
    "date": "07/15/22",
    "document_type": "court document",
    "has_handwriting": false,
    "has_stamps": false
  },
  "full_text": "Case 1:20-cr-00330-PAE Document 734 Filed 07/15/22 Page 5 of 16\n\nNovember 19, 2021\nPage Five\n\nEstate.\"22 The program is also \"purely voluntary\"; claimants' rights are not impacted unless and until they accept an offer of compensation and execute a release.23 Victims were also eligible to participate \"regardless of where they were harmed, when they were harmed, whether the claim is time-barred by the applicable statute of limitations, and whether they have previously filed a lawsuit against or settled with Epstein and/or the Estate.\"24\n\nAnd as critically relevant here, the EVCP is confidential.25 The EVCP and Ms. Feldman repeatedly emphasized the importance of confidentiality to the integrity of the program and the assurance that the EVCP would keep confidential victims' participation in the program and any documents and other information submitted to, maintained by, exchanged with, or distributed by the program.26 Ms. Feldman's probate-court testimony, the Protocol, the FAQs, the EVCP website, and EVCP press releases all highlight the program's promise to maintain confidentiality of claimants' information and how that promise is a \"cornerstone\" of the EVCP.27 Victims relied upon the condition of strict confidentiality in agreeing to support the existence of the Program and in deciding to participate in the claims process.28\n\n22 See https://www.epsteinvcp.com/; see also Ex. D at 1 (Protocol).\n23 Ex. D at 1 (Protocol).\n24 Ex. D at 2 (Protocol).\n25 Ex. D at 2, 6, 8-9 (Protocol).\n26 Ex. A 9 8-12 (Feldman Decl.).\n27 See:\n- Ex. H at 111:1-111:16, 118:9-118:24 (testimony).\n- Ex. D at 8-9 (Protocol section on \"Confidentiality/Privacy\").\n- Ex. E at 9 (FAQs no. 11).\n- https://www.epsteinvcp.com/ (website noting claimant privacy of \"paramount importance\").\n- Ex. C at 2 (6/25/20 Press Release noting claimant privacy of \"paramount importance\").\n- Ex. F at 1 (8/9/21 Press Release noting confidentiality \"critical to the success\" and a \"cornerstone\" of the EVCP).\n28 See Ex. A ¶¶ 7-8, 12 (Feldman Decl.).\n\nDOJ-OGR-00011455",
  "text_blocks": [
    {
      "type": "printed",
      "content": "Case 1:20-cr-00330-PAE Document 734 Filed 07/15/22 Page 5 of 16",
      "position": "header"
    },
    {
      "type": "printed",
      "content": "November 19, 2021\nPage Five",
      "position": "top"
    },
    {
      "type": "printed",
      "content": "Estate.\"22 The program is also \"purely voluntary\"; claimants' rights are not impacted unless and until they accept an offer of compensation and execute a release.23 Victims were also eligible to participate \"regardless of where they were harmed, when they were harmed, whether the claim is time-barred by the applicable statute of limitations, and whether they have previously filed a lawsuit against or settled with Epstein and/or the Estate.\"24\n\nAnd as critically relevant here, the EVCP is confidential.25 The EVCP and Ms. Feldman repeatedly emphasized the importance of confidentiality to the integrity of the program and the assurance that the EVCP would keep confidential victims' participation in the program and any documents and other information submitted to, maintained by, exchanged with, or distributed by the program.26 Ms. Feldman's probate-court testimony, the Protocol, the FAQs, the EVCP website, and EVCP press releases all highlight the program's promise to maintain confidentiality of claimants' information and how that promise is a \"cornerstone\" of the EVCP.27 Victims relied upon the condition of strict confidentiality in agreeing to support the existence of the Program and in deciding to participate in the claims process.28",
      "position": "middle"
    },
    {
      "type": "printed",
      "content": "22 See https://www.epsteinvcp.com/; see also Ex. D at 1 (Protocol).\n23 Ex. D at 1 (Protocol).\n24 Ex. D at 2 (Protocol).\n25 Ex. D at 2, 6, 8-9 (Protocol).\n26 Ex. A 9 8-12 (Feldman Decl.).\n27 See:\n- Ex. H at 111:1-111:16, 118:9-118:24 (testimony).\n- Ex. D at 8-9 (Protocol section on \"Confidentiality/Privacy\").\n- Ex. E at 9 (FAQs no. 11).\n- https://www.epsteinvcp.com/ (website noting claimant privacy of \"paramount importance\").\n- Ex. C at 2 (6/25/20 Press Release noting claimant privacy of \"paramount importance\").\n- Ex. F at 1 (8/9/21 Press Release noting confidentiality \"critical to the success\" and a \"cornerstone\" of the EVCP).\n28 See Ex. A ¶¶ 7-8, 12 (Feldman Decl.).",
      "position": "bottom"
    },
    {
      "type": "printed",
      "content": "DOJ-OGR-00011455",
      "position": "footer"
    }
  ],
  "entities": {
    "people": [
      "Ms. Feldman",
      "Epstein"
    ],
    "organizations": [
      "EVCP"
    ],
    "locations": [],
    "dates": [
      "November 19, 2021",
      "07/15/22",
      "6/25/20",
      "8/9/21"
    ],
    "reference_numbers": [
      "1:20-cr-00330-PAE",
      "734",
      "DOJ-OGR-00011455"
    ]
  },
  "additional_notes": "The document appears to be a court filing related to the Epstein Victim Compensation Program (EVCP). It discusses the confidentiality of the program and the importance of maintaining the privacy of claimants. The document includes references to various exhibits and court filings."
}